Patricio Riva Posse, MD
Psychiatry · Atlanta, GANPI 1669636536
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Livanova USA, Inc. at 41.2% of the total. 2025 is the largest year on record at $57,630, 4.4 times the $13,183 reported in 2019. Among psychiatry clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $664.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$50K
- Abbott$36K
- Janssen Scientific Affairs, LLC$24K
- Johnson & Johnson$12K
Across 206 payments — averaging $3698.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$511K
- Abbott$250K
What the payments were for
- Consulting fees$49,91841%
- Speaking & faculty fees$48,65440%
- Travel & lodging$18,79115%
- Food & beverage$4,3274%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 71 | $50,177 |
| Abbott | 76 | $35,587 |
| Janssen Scientific Affairs, LLC | 24 | $24,214 |
| Johnson & Johnson | 12 | $11,710 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy Symmetry Model 8103 Generator$48,067
- SPRAVATO$35,382
- INFINITY$27,017
- PROCLAIM$7,667
- INVEGA SUSTENNA$2,180
- VNS Therapy$975
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$225
- VNS - Symmetry$110
How this compares
$121,688 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 22 | $1,103 |
| Clonazepam | 32 | $243 |
| Duloxetine Hcl | 18 | $180 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Atlanta
- David PurselleAtlanta$307K
- Michael BurkeAtlanta$217K
- Bryon EvansAtlanta$211K
- Kerry ResslerAtlanta$196K
- Ray HorwitzAtlanta$64K
- Boadie DunlopAtlanta$61K
- Zohaib HaqueAtlanta$49K
- Raymond KotwickiAtlanta$44K
- Joseph BergerAtlanta$24K
- Dwight OwensAtlanta$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.